Sucralfate protects intestinal epithelial cells from radiation-induced apoptosis in rats

J Radiat Res. 2006 Mar;47(1):1-8. doi: 10.1269/jrr.47.1.

Abstract

Radiotherapy for malignant pelvic disease is often followed by acute radiation colitis (ARC). It has been reported that sucralfate treatment has a protective effect against ARC, though the mechanisms of action are unknown. The effects of sucralfate on X-ray radiation-induced apoptosis was studied at 4 Gy in the colonic crypt cells of rats. Sucralfate enemas given prior to radiation resulted in the following: (1) reduction in number of apoptotic colonic crypt cells; (2) reduction in number of caspase-3 positive cells; (3) decreases in p53 accumulation and p21 expression; (4) decreases of Bax/Bcl-2 ratio. The protective effects of sucralfate against ARC may be partially due to the suppression of radiation-induced apoptosis by way of p53 in the colon and the protection of the colonic epithelial stem cell region.

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Cells, Cultured
  • Epithelial Cells / drug effects
  • Epithelial Cells / pathology
  • Epithelial Cells / radiation effects
  • Intestinal Mucosa / drug effects*
  • Intestinal Mucosa / pathology
  • Intestinal Mucosa / radiation effects*
  • Male
  • Radiation Injuries / etiology
  • Radiation Injuries / pathology
  • Radiation Injuries / prevention & control*
  • Radiation-Protective Agents / administration & dosage
  • Rats
  • Rats, Wistar
  • Sucralfate / administration & dosage*
  • Treatment Outcome
  • Whole-Body Irradiation

Substances

  • Radiation-Protective Agents
  • Sucralfate